20. Oral contraceptives, hormone replacement therapy and breast cancer.
about
Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.Breast cancer risk factors in Turkish women--a University Hospital based nested case control study
P2860
20. Oral contraceptives, hormone replacement therapy and breast cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@ast
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@en
type
label
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@ast
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@en
prefLabel
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@ast
20. Oral contraceptives, hormone replacement therapy and breast cancer.
@en
P1476
20. Oral contraceptives, hormone replacement therapy and breast cancer
@en
P2093
Fentiman IS
P304
P577
2002-12-01T00:00:00Z